Literature DB >> 30023073

Years of life lost due to malignant neoplasms of the digestive system in Poland in the years 2000-2014.

Paulina Paciej-Gołębiowska1, Małgorzata Pikala1, Irena Maniecka-Bryła1.   

Abstract

BACKGROUND: Every fourth death that occurs in Poland is caused by a malignant neoplasm. A particularly negative epidemiological situation relates to colorectal cancers; in 2015 they constituted the fifth most important cause of years of life lost (YLL) in Poland.
OBJECTIVE: We aimed to analyse YLL due to malignant neoplasms of the digestive system in Poland in between 2000 and 2014.
METHODS: The study material included a database containing information gathered from 5,601,568 death certificates of Poles who died in 2000-2014. YLLs were calculated with the use of the standard expected years of life lost index (SEYLL).
RESULTS: In the 15-year study period, malignant neoplasms of the digestive system contributed to 213,041 deaths in males and 177,644 deaths in females, which corresponded to a loss of 158.6 years per 10,000 men and 105.3 years per 10,000 women. Neoplasms of the large intestine (23.6%), stomach (22.0%) and pancreas (17.4%) contributed the most. A time trend analysis revealed (p < 0.05) a growing tendency of YLLs due to neoplasms of the large intestine and pancreas, and a decreasing trend due to neoplasms of the stomach.
CONCLUSION: Malignant neoplasms of the digestive system, especially of the large intestine, are becoming a more common cause of premature mortality in Poland.

Entities:  

Keywords:  Malignant neoplasms; SEYLL; digestive system; premature mortality; years of life lost

Year:  2018        PMID: 30023073      PMCID: PMC6047295          DOI: 10.1177/2050640618764714

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  24 in total

1.  Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.

Authors:  Fatima A Haggar; Robin P Boushey
Journal:  Clin Colon Rectal Surg       Date:  2009-11

2.  Lost life years due to premature deaths caused by diseases of the digestive system in Poland in 2013

Authors:  Paulina Paciej; Beata Ciabiada; Irena Maniecka-Bryła
Journal:  Przegl Epidemiol       Date:  2016

3.  Gastric cancer: epidemiology and risk factors.

Authors:  Guenter J Krejs
Journal:  Dig Dis       Date:  2010-11-18       Impact factor: 2.404

Review 4.  Epidemiology of gastric cancer.

Authors:  Katherine D Crew; Alfred I Neugut
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

5.  Are dietary habits of the Polish population consistent with the recommendations for prevention of cardiovascular disease? - WOBASZ II project.

Authors:  Anna Waśkiewicz; Danuta Szcześniewska; Dorota Szostak-Węgierek; Magdalena Kwaśniewska; Andrzej Pająk; Urszula Stepaniak; Krystyna Kozakiewicz; Andrzej Tykarski; Tomasz Zdrojewski; Małgorzata E Zujko; Wojciech Drygas
Journal:  Kardiol Pol       Date:  2016-01-18       Impact factor: 3.108

6.  Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors.

Authors:  Sara Raimondi; Patrick Maisonneuve; J-Matthias Löhr; Albert B Lowenfels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

7.  Economic burden of cancer across the European Union: a population-based cost analysis.

Authors:  Ramon Luengo-Fernandez; Jose Leal; Alastair Gray; Richard Sullivan
Journal:  Lancet Oncol       Date:  2013-10-14       Impact factor: 41.316

8.  Years of life lost as a measure of cancer burden on a national level.

Authors:  O T Brustugun; B Møller; A Helland
Journal:  Br J Cancer       Date:  2014-07-01       Impact factor: 7.640

9.  Fifteen-year mortality trends in Poland analysed with the use of standard expected years of life lost, 2000-2014.

Authors:  Małgorzata Pikala; Irena Maniecka-Bryła
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 10.  Epidemiology of pancreatic cancer.

Authors:  Milena Ilic; Irena Ilic
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.